FDA Watch: New Warning Letter May Signal Resurgence of LDT Enforcement Activity

 Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
April 30, 2019  
placeholder INDUSTRY BUZZ
FDA Watch: New Warning Letter May Signal Resurgence of LDT Enforcement Activity
From Laboratory Industry Report
After a couple of years of dormancy, the FDA laboratory developed test (LDT) enforcement volcano stirred on…
Read More
placeholder TESTING STRATEGY
Microbiology Testing Rates Low For Hospital-Acquired Infections
From Diagnostic Testing & Emerging Technologies
The European Centre for Disease Control and Prevention (ECDC) estimates that there are 9 million cases of health care-associated infections…
Read More
placeholder OIG
Medicaid Fraud Enforcement Trends By the Numbers
From National Intelligence Report
A new report from OIG details Medicare Fraud Control Unit (MCFU) enforcement activity in fiscal year…
Read More
placeholder ENFORCEMENT
Case of the Month: Another MD-Owned Lab Gets Busted for Urine Drug Test Abuses
From Lab Compliance Advisor
Fraudulent utilization and billing of urine drug screening first became a priority for federal enforcers since the…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2019, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320